← Back to contracts

STTR Phase I: A Novel Biosensing Device for Rapidly Mapping Volumetric Tumor Margins

US NSF grant open #nsf-2451826

Summary

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel sensor to better detect tumor margins during surgical interventions for cancer. Cancer remains a substantial global healthcare burden due to high treatment costs, long-term care needs, and reduced quality of life. The limitations of existing sensor technologies include challenges with identifying tumor location or boundaries, often resulting in incomplete tumor removal. Inadequate resections contributes to cancer recurrence, requiring additional surgeries and treatments. This pr

STTR Phase I: A Novel Biosensing Device fo…
Onboard